{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:42:30Z","timestamp":1790502150658,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ghir.2021.101393","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:40:31Z","timestamp":1619743231000},"page":"101393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue"],"prefix":"10.1016","volume":"57-58","author":[{"given":"Nigel","family":"Glynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Halsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Boran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmuid","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malachi J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2021.101393_bb0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cen.13272","article-title":"The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies","volume":"86","author":"Glynn","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","article-title":"Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients","volume":"66","author":"Agha","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0015","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","article-title":"Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: When does L-T4 therapy become mandatory?","volume":"87","author":"Porretti","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/thy.2008.0266","article-title":"Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency","volume":"18","author":"Losa","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2021.101393_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12020-017-1495-y","article-title":"Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans","volume":"59","author":"Yamauchi","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2021.101393_bb0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1210\/jcem-72-6-1189","article-title":"Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers","volume":"72","author":"Harvey","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/thy.1996.6.75","article-title":"Fine adjustments in thyroxine replacement and its effect on bone metabolism","volume":"6","author":"Campbell","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2021.101393_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2265.1997.1280950.x","article-title":"Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine","volume":"46","author":"Guo","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/eje.0.1380667","article-title":"Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy","volume":"138","author":"Toivonen","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0039-128X(68)80009-1","article-title":"Studies on the binding of testosterone to human plasma","volume":"11","author":"Vermeulen","year":"1968","journal-title":"Steroids"},{"key":"10.1016\/j.ghir.2021.101393_bb0055","first-page":"116","article-title":"Effects of thyroid hormone on sex hormone-binding globulin gene expression in human cells","volume":"75","author":"Raggatt","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","article-title":"Sex-hormone-binding globulin","volume":"3","author":"Anderson","year":"1974","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0065","series-title":"Werner Ingbar's Thyroid A Fundam. Clin. Text","first-page":"397","article-title":"Metabolic, physiologic, and clinical indexes of thyroid function","author":"Smallridge","year":"1996"},{"key":"10.1016\/j.ghir.2021.101393_bb0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7326\/0003-4819-96-5-617","article-title":"Increased serum ferritin levels in hyperthyroidism","volume":"96","author":"Macaron","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2021.101393_bb0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1210\/jcem-61-4-672","article-title":"Serum ferritin as a marker of thyroid hormone action on peripheral tissues","volume":"61","author":"Takamatsu","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2021.101393_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(87)90447-5","article-title":"Serum lipids in hyper- and hypothyroidism before and after treatment","volume":"162","author":"Friis","year":"1987","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ghir.2021.101393_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/BTER:97:2:125","article-title":"Study of trace elements in blood of thyroid disorder subjects before and after 131I Therapy","volume":"97","author":"Zhang","year":"2004","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ghir.2021.101393_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/BJ20111817","article-title":"Serum copper as a novel biomarker for resistance to thyroid hormone","volume":"443","author":"Mittag","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.ghir.2021.101393_bb0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/thy.1998.8.1029","article-title":"Serum creatine kinase levels in overt and subclinical hypothyroidism","volume":"8","author":"Beyer","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2021.101393_bb0105","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ghir.2021.101393_bb0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4158\/EP-2017-0223","article-title":"Alterations in thyroid hormone levels following growth hormone replacement exert complex biological effects","volume":"24","author":"Glynn","year":"2018","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ghir.2021.101393_bb0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","article-title":"Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system","volume":"47","author":"Hoefner","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2021.101393_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ghir.2006.11.002","article-title":"Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response","volume":"17","author":"Svensson","year":"2007","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2021.101393_bb0130","first-page":"924","article-title":"Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism","volume":"84","author":"Ferretti","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0135","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1210\/jc.2007-0297","article-title":"Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine","volume":"92","author":"Slawik","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0140","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.2001.01417.x","article-title":"Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult gh deficiency","author":"Sohmiya","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0145","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency 1","author":"Christ","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12020-015-0781-9","article-title":"Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency","author":"Esposito","year":"2016","journal-title":"Endocrine."},{"key":"10.1016\/j.ghir.2021.101393_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2265.1996.635457.x","article-title":"Continuous subcutaneous infusion of low dose growth hormone decreases serum sex-hormone binding globulin and testosterone concentrations in moderately obese middle-aged men","volume":"44","author":"Oscarsson","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2265.2006.02655.x","article-title":"Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency","volume":"65","author":"Giavoli","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0165","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.2012-1616","article-title":"Central hypothyroidism: pathogenic, diagnostic and therapeutic challenges","volume":"97","author":"Persani","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0170","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/bmj.306.6894.1726-a","article-title":"Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment","volume":"306","author":"Olivecrona","year":"1993","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2021.101393_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1994.tb02555.x","article-title":"The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients","volume":"41","author":"Russell-Jones","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2265.2008.03509.x","article-title":"Effects of 18 months of l-T4 replacement in women with subclinical hypothyroidism","volume":"71","author":"Adrees","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0185","first-page":"121","article-title":"Lipoprotein(a) and apolipoprotein b plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects","volume":"76","author":"De Bruin","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.1997.2351057.x","article-title":"Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH","volume":"47","author":"Persani","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study","volume":"54","author":"Drake","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","article-title":"Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency: a randomized, placebo-controlled trial","volume":"125","author":"Baum","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2021.101393_bb0205","first-page":"3352","article-title":"Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study","volume":"81","author":"Hansen","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-017-1440-0","article-title":"Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis","volume":"59","author":"Barake","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2021.101393_bb0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF03343851","article-title":"Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency","volume":"24","author":"Sartorio","year":"2001","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2021.101393_bb0220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/BF03348952","article-title":"Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover","volume":"16","author":"Sartorio","year":"1993","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2021.101393_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","author":"Giustina","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2021.101393_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis","author":"Mazziotti","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0235","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1210\/jc.2003-030772","article-title":"Pegvisomant-induced serum insulin-like growth factor-i normalization in patients with acromegaly returns elevated markers of bone turnover to normal","author":"Parkinson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101393_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-13-0596","article-title":"Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients","volume":"170","author":"Behan","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0245","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ghir.2021.101393_bb0250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.2005.02333.x","article-title":"Endocrine regulation of bone turnover in men","volume":"63","author":"Meier","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101393_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1203\/00006450-200208000-00003","article-title":"Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth","author":"Robson","year":"2002","journal-title":"Pediatr. Res."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:25Z","timestamp":1761087145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"alternative-id":["S1096637421000162"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101393","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101393"}}